NX, C., SY, Z., RY, C., S, W., Q, L., Y, Z., & XZ, L. (2026). Subcutaneous ofatumumab for remission maintenance in pediatric idiopathic nephrotic syndrome: A case series. Clinical kidney journal, 19(7), sfag169. https://doi.org/10.1093/ckj/sfag169
Chicago Style (17th ed.) CitationNX, Cui, Zhu SY, Chen RY, Wu S, Lin Q, Zhu Y, and Li XZ. "Subcutaneous Ofatumumab for Remission Maintenance in Pediatric Idiopathic Nephrotic Syndrome: A Case Series." Clinical Kidney Journal 19, no. 7 (2026): sfag169. https://doi.org/10.1093/ckj/sfag169.
MLA (9th ed.) CitationNX, Cui, et al. "Subcutaneous Ofatumumab for Remission Maintenance in Pediatric Idiopathic Nephrotic Syndrome: A Case Series." Clinical Kidney Journal, vol. 19, no. 7, 2026, p. sfag169, https://doi.org/10.1093/ckj/sfag169.